AIGH Capital Management LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1835943
BALTIMORE, MD
Position in ESPR
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$0
+$0 QoQ
Shares Held
4,400,000
+10.0% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 73%
Shared 27%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AIGH Capital Management LLC holds $5,439,500 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 4,400,000 | Shares | Other | 2026-04-30 | |
| 2025-12-31 | — | 4,000,000 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | — | 3,000,000 | Shares | Other | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||